KRT5 and breast carcinoma: Immunohistochemical profiles of the BRCA1-mutation breast cancer are featured by expression of cytokeratin (CK) 5/6 and CK14, contributing to the increasing risk of breast cancer (Rigakos & Razis, 2012).